J P Vernant

3.1k citations

49 papers · 2.0k indexed · h-index 24

Hematology top 0.5%
Immunology top 5%
Public Health, Environmental and Occupational Health top 2%
Oncology top 10%
Genetics top 2%

Co-authors: Mathieu Kuentz B Dreyfus Éliane Gluckman Catherine Sebban V. Leblond Éric Lepage J Reiffers Bernard Brun
Topics: Hematopoietic Stem Cell Transplantation (23 papers)Acute Myeloid Leukemia Research (15 papers)Acute Lymphoblastic Leukemia research (10 papers)
Cited by: Hematology Genetics Immunology
Journals: Journal of Clinical Investigation Journal of Clinical Oncology The Journal of Immunology
Partner nations: France Switzerland Netherlands

In The Last Decade

J P Vernant

49 papers receiving 1.9k citations

Peers

Countries citing papers authored by J P Vernant

Since Specialization

Citations

This map shows the geographic impact of J P Vernant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J P Vernant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J P Vernant more than expected).

Fields of papers citing papers by J P Vernant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J P Vernant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J P Vernant. The network helps show where J P Vernant may publish in the future.

Co-authorship network of co-authors of J P Vernant

This figure shows the co-authorship network connecting the top 25 collaborators of J P Vernant. A scholar is included among the top collaborators of J P Vernant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J P Vernant. J P Vernant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First French experiences of total body irradiations using helical TomoTherapy® 2017 ·Cancer/Radiothérapie ·Roger Sun,X. Cuenca,(unknown),Stéphanie Nguyen Quoc,J P Vernant,J.J. Mazeron,(unknown),M. Chéa	18
2	Volontariat et don de sang : compte rendu d’un séminaire de l’Institut national de transfusion sanguine 2016 ·Transfusion Clinique et Biologique ·Olivier Garraud,Bruno Danic,J.-P. Cartron,Jacques Chiaroni,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Sophia Moreau,(unknown),(unknown),(unknown),(unknown),(unknown),Jean‐Daniel Tissot,J P Vernant,(unknown)	5
3	Bronchiolite oblitérante après allogreffe de cellules souches hématopoïétiques : quels progrès ? 2011 ·Revue de Pneumologie Clinique ·François Lemonnier,Nathalie Dhédin,É. Catherinot,Colas Tchérakian,H. Neveu,Felipe Suárez,M.H. Becquemin,Philippe Devillier,J P Vernant,L.J. Couderc,É. Rivaud	2
4	Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia 2009 ·Haematologica ·(unknown),F. Huguet,Thibaut Leguay,Francis Lacombe,Marc Maynadié,Steven Girard,Adrienne de Labarthe,Emilienne Kühlein,Emmanuel Raffoux,X. Thomas,Patrice Chevallier,Agnès Buzyn,André Delannoy,Yves Chalandon,J P Vernant,Philippe Rousselot,Elizabeth Macintyre,Norbert Ifrah,Hervé Dombret,Marie C. Béné	71
5	HLA-E upregulation on IFN-γ-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT 2008 ·Bone Marrow Transplantation ·Stéphanie Nguyen,Vivien Béziat,Nathalie Dhédin,Mathieu Kuentz,J P Vernant,Patrice Debré,Vincent Vieillard	75
6	Involvement of mature donor T cells in the NK cell reconstitution after haploidentical hematopoietic stem-cell transplantation 2007 ·Leukemia ·Stéphanie Nguyen,M Kuentz,J P Vernant,Nathalie Dhédin,Dominique Bories,Patrice Debré,Vincent Vieillard	43
7	Approche diagnostique d’une pneumopathie chez un malade atteint d’hémopathie maligne 2007 ·Revue des Maladies Respiratoires ·Nathalie Dhédin,É. Rivaud,Philippe Bouvet,A Scherrer,Élisabeth Longchampt,P. Honderlick,É. Catherinot,J P Vernant,L.J. Couderc	5
8	Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia 2006 ·Leukemia ·Vahid Asnafi,(unknown),Éric Delabesse,Emmanuel Villar,(unknown),Gandhi Damaj,Ivan Hirsch,Nathalie Dhédin,J P Vernant,Bruno Varet,Agnès Buzyn,Elizabeth Macintyre	13
9	Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials 2005 ·Leukemia ·Nathalie Dhédin,Hervé Dombret,Xavier Thomas,Véronique Lhéritier,J.-M. Boiron,Françoise Rigal‐Huguet,Norbert Vey,Mathieu Kuentz,Oumédaly Reman,Francis Witz,André Delannoy,Tibor Kovacsovics,Kenneth F. Bradstock,C Charrin,Claude Boucheix,J Gäbert,Didier Blaise,D Fière,J P Vernant	28
10	Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia. 1998 ·Journal of Clinical Investigation ·Patricia Yotnda,Hüseyin Firat,Francisco Garcia‐Pons,Zacarias Garcia,(unknown),J P Vernant,François A. Lemonnier,V. Leblond,Pierre Langlade‐Demoyen	193
11	Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan) 1997 ·Bone Marrow Transplantation ·Éric Deconinck,J Cahn,Nöel Milpied,J P Jouet,J P Vernant,Hélène Espérou,Bruno Lioure,Pierre Bordigoni,V. Leblond,Xavier Troussard,Denis Caillot,(unknown),P Hervé	22
12	Bone-Marrow Transplantation in Sickle-Cell Disease 1997 ·Journal of Bone and Joint Surgery ·Philippe Hernigou,Françoise Bernaudin,P Reinert,Mathieu Kuentz,J P Vernant	65
13	Influence of clinical status on the efficiency of stored platelet transfusion 1994 ·British Journal of Haematology ·Françoise Norol,M Kuentz,Charlotte Cordonnier,F. Beaujean,Corinne Haïoun,J P Vernant,N. Duédari	55
14	Influence du statut clinique sur l'efficacité transfusionnelle des plaquettes conservées 1993 ·PubMed ·Françoise Norol,M Kuentz,Charlotte Cordonnier,F. Beaujean,(unknown),J P Vernant,N. Duédari	5
15	Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb. 1993 ·The Journal of Immunology ·Matthieu Rouleau,Alain Bernard,Olivier Lantz,J P Vernant,B Charpentier,A Senik	39
16	Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) 1990 ·British Journal of Haematology ·(unknown),F. E. Zwaan,J Hermans,J P Vernant,Hans‐Jochem Kolb,J M Vossen,B Lönnqvist,Dietrich W. Beelen,Augustin Ferrant,J Gmür,(unknown),X. Troussard,Jean‐Yves Cahn,(unknown),(unknown)	139
17	Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission. 1990 ·Journal of Clinical Oncology ·Xavier Troussard,V. Leblond,Mathieu Kuentz,Nöel Milpied,J P Jouet,Catherine Cordonnier,M Leporrier,J P Vernant	27
18	Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse. 1989 ·Journal of Clinical Oncology ·Pierre Bordigoni,J P Vernant,G Souillet,Éliane Gluckman,(unknown),Nöel Milpied,Anja Fischer,(unknown),J P Jouet,J Reiffers	47
19	Selective depletion of marrow-T cytotoxic lymphocytes (CD8) in the prevention of graft-versus-host disease after allogeneic bone-marrow transplantation 1988 ·Transplant International ·D Maraninchi,Claude Mawas,Denis Guyotat,Josy Reiffers,J P Vernant,N Gratecos,(unknown),G Novakovitch	15
20	Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission. 1988 ·Journal of Clinical Oncology ·J P Vernant,Gérald Marit,D Maraninchi,Denis Guyotat,Mathieu Kuentz,Catherine Cordonnier,J Reiffers	40

About J P Vernant

J P Vernant is a scholar working on Hematology, Transplantation and Genetics, having authored 49 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (23 papers), Acute Myeloid Leukemia Research (15 papers) and Acute Lymphoblastic Leukemia research (10 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (365 citations) and Immunology (638 citations). J P Vernant has collaborated with scholars based in France, Switzerland and Netherlands. Frequent co-authors include Mathieu Kuentz, B Dreyfus, Éliane Gluckman, Catherine Sebban, V. Leblond, Éric Lepage, J Reiffers, Bernard Brun, Nathalie Dhédin and Jean‐Yves Cahn. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact